Next Quarterly Earnings
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Johnson & Johnson is a leading US-based global healthcare company focused on developing and providing innovative pharmaceuticals and medical technology solutions. The company is dedicated to advancing global human health, sustainably optimizing patient lives, and enhancing quality of life through its cutting-edge products and therapies.
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Johnson & Johnson (JNJ) reported its Q2 2026 results on July 15, 2026, before market open. The company reported an EPS of 2.90 USD, beating the analyst estimate of 2.85 USD by 1.6%. Revenue reached 25310 million USD for the quarter. Following the release, the stock price decreased by 2.69%.
Generated automatically from our data — as of 07/23/2026 Read the article →
Johnson & Johnson is scheduled to report its next quarterly earnings on 10/20/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Johnson & Johnson last reported quarterly earnings on 7/15/2026 (Q2 2026). Earnings per share (EPS) came in at 2.90 USD.
Across its last 5 earnings reports, Johnson & Johnson stock moved by ±1.1% on average the following day. The largest reaction was -2.7% on 07/15/2026; 1 of 5 reactions were positive.
Johnson & Johnson has beaten analyst EPS estimates in 4 of its last 5 evaluated quarters (beat rate: 80%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 5 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.